Des Moines, IA, United States of America

Charles J Link, Jr

This inventor holds 10 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Human Gene Therapy Research Institute, Newlink Genetics Corporation. Active years: 1998-2006.

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 60.0

EPO Patents = 1

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 84(Granted Patents)

Location History:

Des Moines, IA (US) (1998 - 2006)
Ames, IA (US) (2006)

Company Filing History:

8 out of 11

Human Gene Therapy Research Institute

patents

2 out of 22

Newlink Genetics Corporation

patents

Years Active: 1998-2006

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7125549 - Methods and compositions for efficient gene transfer using transcomplementary vectors (2006-10-24),

2. 7078179 - Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase (2006-07-18),

3. 7029665 - Human suppressor tRNA oligonucleotides and methods for use for same (2006-04-18),

4. 6897020 - Methods and compositions for elucidating relative protein expression levels in cells (2005-05-24),

5. 6875610 - Methods and compositions for efficient gene transfer using transcomplementary vectors (2005-04-05),

6. 6541197 - Vehicles for stable transfer of green fluorescent protein gene and methods of use for same (2003-04-01),

7. 6309830 - Human suppressor tRNA oligonucleotides and methods of use for same (2001-10-30),

8. 5985266 - Radiation enhanced therapy for tumors expressing a gene for viral (1999-11-16),

9. 5843459 - Differential inactivation of nucleic acids by chemical modification (1998-12-01),

10. 5830727 - Herpes simplex virus amplicon mini-vector gene transfer system (1998-11-03),

Title: Innovator Spotlight: Charles J Link, Jr.

Introduction: Meet the brilliant inventor, Charles J Link, Jr, hailing from Des Moines, IA (US), who has made significant contributions in the field of gene transfer and marker systems.

Latest Patents: Charles J Link, Jr's latest patents include innovative methods and compositions for efficient gene transfer using transcomplementary vectors, enhancing gene delivery and expression. Another patent introduces a selectable gene marker system based on the expression of N-acetyllactosaminide 3-α galactosyltransferase, revolutionizing cell identification and isolation processes.

Career Highlights: Charles J Link, Jr has showcased his expertise at renowned institutions such as the Human Gene Therapy Research Institute and Newlink Genetics Corporation, where he has played a pivotal role in shaping advancements in genetic research and biotechnology.

Collaborations: Throughout his career, Charles J Link, Jr has collaborated with esteemed professionals like James N Higginbotham and Suming Wang, fostering a culture of innovation and knowledge sharing within the industry.

Conclusion: With 10 patents to his name and a legacy of groundbreaking inventions, Charles J Link, Jr stands as a prominent figure in the realm of genetic research, continually pushing the boundaries of possibility and shaping the future of biotechnology.